PTEN INACTIVATION AND ALTERATION OF THE PI3K/AKT/mTOR PATHWAY IN BILIARY TRACT CANCER

被引：0
|
作者：
Petzold, J. [1 ]
Lederer, E. [1 ]
Reihs, R. [1 ]
Ernst, C. [1 ]
Bettermann, K. [1 ]
Halbwedl, I. [1 ]
Lax, S. [2 ]
Park, Y. N. [3 ]
Kim, K. S. [4 ]
Kiesslich, T. [5 ]
Pichler, M. [6 ]
Obrist, P. [7 ]
Haybaeck, J. [1 ]
机构：
[1] Med Univ Graz, Inst Pathol, Graz, Austria
[2] Hosp Graz West, Dept Pathol, Graz, Austria
[3] Yonsei Univ, Coll Med, Dept Pathol, Project Med Sci BK21PLUS, Seoul, South Korea
[4] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea
[5] Paracelsus Med Univ, Inst Physiol & Pathophysiol, Salzburg, Austria
[6] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA
[7] Inst Pathol, Zams, Austria
来源：
ANTICANCER RESEARCH | 2014年 / 34卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
244
引用
收藏
页码：5942 / 5943
页数：2
相关论文
共 50 条
  • [31] PI3K/AKT/mTOR
    Umemura, Shigeki
    Goto, Koichi
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S116 - S117
  • [32] Loss of PTEN expression in patients treated with PI3K/AKT/mTOR signaling pathway inhibitors
    Janku, Filip
    Garrido-Laguna, Ignacio
    Tsimberidou, Apostolia M.
    Naing, Aung
    Fu, Siqing
    Falchook, Gerald S.
    Abraham, Susan C.
    Hong, David S.
    Kurzrock, Razelle
    CANCER RESEARCH, 2011, 71
  • [33] A computational model for the PI3K/Akt/mTOR pathway predicts PTEN as a negative feedback loop
    Vanaja, Kiran
    Mukherjee, Radha
    Rosen, Neal
    Levchenko, Andre
    CANCER RESEARCH, 2020, 80 (16)
  • [34] The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers
    Paplomata, Elisavet
    O'Regan, Ruth
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2014, 6 (04) : 154 - 166
  • [35] Inhibition of the PI3K/AKT/mTOR pathway in pancreatic cancer: is it a worthwhile endeavor?
    Ouissam, Al Jarroudi
    Hind, Chibani
    Aziz, Brahmi Sami
    Said, Afqir
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [36] PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer
    Li, HaiXia
    Zeng, JianFang
    Shen, Keng
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2014, 290 (06) : 1067 - 1078
  • [37] Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancer
    S-U Woo
    T Sangai
    A Akcakanat
    H Chen
    C Wei
    F Meric-Bernstam
    Oncogenesis, 2017, 6 : e385 - e385
  • [38] Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention
    Roudsari, Nazanin Momeni
    Lashgari, Naser-Aldin
    Momtaz, Saeideh
    Abaft, Shaghayegh
    Jamali, Fatemeh
    Safaiepour, Pardis
    Narimisa, Kiyana
    Jackson, Gloria
    Bishayee, Anusha
    Rezaei, Nima
    Abdolghaffari, Amir Hossein
    Bishayee, Anupam
    PHARMACEUTICS, 2021, 13 (08)
  • [39] Targeting the PI3K/AKT/mTOR pathway: potential for lung cancer treatment
    Cheng, Haiying
    Shcherba, Marina
    Pendurti, Gopichand
    Liang, Yuanxin
    Piperdi, Bilal
    Perez-Soler, Roman
    LUNG CANCER MANAGEMENT, 2014, 3 (01) : 67 - 75
  • [40] Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancer
    Woo, S-U
    Sangai, T.
    Akcakanat, A.
    Chen, H.
    Wei, C.
    Meric-Bernstam, F.
    ONCOGENESIS, 2017, 6 : e385 - e385
12345